Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy

American Journal of Veterinary Research

Volumn 70, Issue 2, 2009, Pages 216-222

  Zimmering, Tanja M ^a   Meneses, Felix ^a   Nolte, Ingo J ^a   Simon, Daniela ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PROATRIAL NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARDIOMYOPATHY; CAT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; THORAX RADIOGRAPHY; THYROXINE BLOOD LEVEL; VENOUS BLOOD;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMYOPATHIES; CAT DISEASES; CATS; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; PROTEIN PRECURSORS; RADIOGRAPHY, THORACIC;

ANIMALIA;

EID: 60749087164     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.2.216     Document Type: Article

References (62)

1. Wei CM, Heublein DM, Perrella MA, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-1009.
2. Schweitz H, Vigne P, Moinier D, et al. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J Biol Chem 1992;267:13928-13932.
3. Sudoh T, Minamino N, Kangawa K, et al. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990;168:863-870.
4. Martinez-Rumayor A, Richards AM, Burnett JC, et al. Biology of the natriuretic peptides. Am J Cardiol 2008;101:3-8.
5. McGrath MF, de Bold ML, de Bold AJ. The endocrine function of the heart. Trends Endocrinol Metab 2005;16:469-477.
6. Wei CM, Kim CH, Miller VM, et al. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest 1993;92:2048-2052.
7. Meyer M, Richter R, Forssmann WG. Urodilatin, a natriuretic peptide with clinical implications. Eur J Med Res 1998;3:103-110.
8. Chen HH, Cataliotti A, Schirger JA, et al. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential actions in overt experimental heart failure. Am J Physiol Regul Integr Comp Physiol 2005;288:R1093-R1097.
9. Schirger JA, Heublein DM, Chen HH, et al. Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure. Mayo Clin Proc 1999;74:126-130.
10. de Bold AJ, Borenstein HB, Veress AT, et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94.
11. Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 1994;235:561-576.
12. Hall C, Ihlen H, Bonarjee V, et al. J. N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease. Int J Cardiol 2003;89:197-205.
13. Vuolteenaho O, Arjamaa O, Ling N. Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids. Biochem Biophys Res Commun 1985;129:82-88.
14. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341-356.
15. Hall C, Aaberge L, Stokk O. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation 1995;91:911.
16. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 1985;230:767-770.
17. de Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroenocrine regulation of the endocrine heart. Cardiovasc Res 1996;31:7-18.
18. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-328.
19. Yap LB, Astrafian H, Mukerjee D, et al. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension. Clin Biochem 2004;37:847-856.
20. Turk JR. Physiologic and pathophysiologic effects of natriuretic peptides and their implications in cardiopulmonary disease. J Am Vet Med Assoc 2000;216:1970-1976.
21. Melo LG, Steinhelper ME, Pang SC, et al. ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. Physiol Genomics 2000;3:45-58.
22. Lang RE, Tholken H, Ganten D, et al. Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature 1985;314:264-266.
23. Ruskoaho H, Tholken H, Lang RE. Increase in atrial pressure releases atrial natriuretic peptide from isolated perfused rat hearts. Pflugers Arch 1986,407:170-174.
24. de Bold AJ, Ma KK, Zhang Y, et al. The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol 2001;79:705-714.
25. Biondo AW, Ehrhart EJ, Sisson DD, et al. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy. Vet Pathol 2003;40:501-506.
26. Hall C, Cannon CP, Forman S, et al. Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. J Am Coll Cardiol 1995;26:1452-1456.
27. Rouleau JL, Packer M, Moyel L, et al. Prognostic value of neurohumoral activation in patients with acute myocardial infarction: effect of captopril. J Am Coll Cardiol 1994;24:583-591.
28. Kitaoka H, Hitomi N, Yabe T, et al. Cardiovascular events and plasma atrial natriuretic peptide level in patients with hypertrophic cardiomyopathy. Am J Cardiol 2001;87:1318-1320.
29. Nagaya N, Ando M, Oya H, et al. Plasma brain natriuretic peptide as a non-invasive marker for efficacy of pulmonary thromboendarterectomy. Ann Thorac Surg 2002;74:180-184.
30. Hara Y, Hamada M, Ohtsuka T, et al. Comparison of treatment effects of bevantolol and metoporol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy. Heart Vessels 2002;17:53-56.
31. Boswood A, Attree S, Page K. Clinical validation of a proANP31-67 fragment ELISA in the diagnosis of heart failure in the dog. J Small Anim Pract 2003;44:104-108.
32. Haggstrom J, Hansson K, Kvart C, et al. Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease. J Vet Cardiol 2000;2:7-16.
33. O'Sullivan ML, O'Grady MR, Minors SL. Plasma Big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrin concentrations in normal Doberman pinschers and Doberman pinschers with dilated cardiomyopathy. J Vet Intern Med 2007;21:92-99.
34. Koie H, Kanayama K, Takeo S, et al. Evaluation of diagnostic availability of continuous ANP assay and La/Ao ratio in left heart insufficient dogs. J Vet Med Sci 2001;63:1237-1240.
35. MacLean HN, Abbott JA, Ward DL, et al. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J Vet Intern Med 2006;20:284-289.
36. Connolly DJ, Soares Magalhaes RJ, Syme HM, et al. Circulating natriuretic peptides in cats with heart disease. J Vet Intern Med 2008;22:96-105.
37. Hori Y, Yamano S, Iwanaga K, et al. Evaluation of plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease. J Vet Intern Med 2008;22:135-139.
38. Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 1993;7:247-252.
39. Hansson K, Haggstrom J, Kvart C, et al. Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement. Vet Radiol Ultrasound 2002;43:568-575.
40. Maerz I, Schober K, Oechtering G. Echocardiographic measurment of left atrial dimension in healthy cats and cats with left ventricular hypertrophy. Tierarztl Prax 2006;34:331-340.
41. Biondo AW, Liu ZL, Wiedmeyer GE, et al. Genomic sequence and cardiac expression of atrial natriuretic peptide in cats. Am J Vet Res 2002;63:236-240.
42. Greco DS, Biller B, Van Liew CH. Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease. Can Vet J 2003;44:293-297.
43. Lerman A, Gibbons RJ, Rodeheffer RJ, et al. Circulating N-terminal atrial natriuretic peptide as marker for symptomless left ventricular dysfunction. Lancet 1993;341:1105-1109.
44. Daggubati S, Parks JR, Overton RM, et al. Adrenomodulin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone compared as early heart failure indicators (Erratum published in Cardiovasc Res 1997;44:452-453). Cardiovasc Res 1997;36:246-255.
45. Davidson NC, Naas AA, Hanson JK, et al. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996;77:828-831.
46. Azizi C, Maistre G, Kalotka H, et al. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with CHF. J Endocrinol 1996;148:51-57.
47. Holmström H, Thaulow E, Stokke O, et al. Serum N-terminal proatrial natriuretic factor in children with congenital heart disease. Eur Heart J 1996;17:1737-1746.
48. Prošek R, Sisson DD, Oyama MA, et al. Distinguishing cardiac and noncardiac dyspnea in 48 dogs using plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I. J Vet Intern Med 2007;21:238-242.
49. Haggstrom J, Hansson K, Karlberg BE, et al. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels. Am J Vet Res 1994;55:698-703.
50. Tidholm A, Haggstrom J, Hansson K. Effects of dilated cardiomyopathy an the rennin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentration in dogs. Am J Vet Res 2001;62:961-967.
51. Gardner DG, Schultz HD. Prostaglandins regulate synthesis and secretion of the atrial natriuretic peptide. J Clin Invest 1990;86:52-59.
52. Witthaut R. Science review: natriuretic peptides in critical illness. Crit Care 2004;8:342-349.
53. Buckley MG, Marcus NJ, Yacoub MH, et al. Prolonged stability of BNP, importance for non-invasive assessment of cardiac function in clinical practice. Clin Sci (Lond) 1998;95:235-239.
54. Hartter E, Khalafpour S, Missbichler A, et al. Enzyme immunoassays for fragments (epitopes) of human proatrial natriuretic peptides. Clin Chem Lab Med 2000;38:27-32.
55. Buckley MG, Marcus NJ, Yacoub MH. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Clin Sci (Lond) 1999;97:689-695.
56. Numata Y, Dohi K, Furukawa A, et al. Immunoradiometric assay for N-terminal fragment of proatrial natriuretic peptide in human plasma. Clin Chem 1998;44:1008-1013.
57. Pedersen KM, Pedersen DP, Haggstrom J, et al. Increased mean arterial pressure and aldosterone-to-renin ratio in Persian cats with polycystic kidney disease. J Vet Intern Med 2003;17:21-27.
58. Toma I, Sax B, Nagy A, et al. Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart. Exp Biol Med (Maywood) 2006;231:847-851.
59. Chetboul V, Tessier-Vetzel D, Escriou C, et al. Diagnostic potential of natriuretic peptides in the occult phase of Golden Retriever muscular dystrophy cardiomyopathy. J Vet Intern Med 2004;18:845-850.
60. Oyama MA, Sisson DD, Solter PF. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res 2007;68:42-47.
61. Takemura G, Fujiwara H, Mukoyama M, et al. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 1991;80:1137-1147.
62. Colbatzky F, Vollmar A, Monch U, et al. Synthesis and distribution of atrial natriuretic peptide (ANP) in hearts from normal dogs and those with cardiac abnormalities. J Comp Pathol 1993;108:149-163.